blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3295948

EP3295948 - USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF POTASSIUM ION CHANNEL MODULATOR MEDICINE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  03.12.2021
Database last updated on 24.01.2025
FormerExamination is in progress
Status updated on  04.09.2020
FormerRequest for examination was made
Status updated on  16.02.2018
FormerThe international publication has been made
Status updated on  18.11.2016
Most recent event   Tooltip03.12.2021Application deemed to be withdrawnpublished on 05.01.2022  [2022/01]
Applicant(s)For all designated states
Shaanxi Momentum Pharmaceutical Co., Ltd.
No. 1 Hancangnan Road
Hi-tech District
Xianyang, Shaanxi 712000 / CN
[2018/12]
Inventor(s)01 / WANG, Baoan
No. 1 Hancangnan Road
Hi-tech District
Xianyang Shaanxi 712000 / CN
02 / MAO, Peng
No. 1 Hancangnan Road
Hi-tech District
Xianyang Shaanxi 712000 / CN
 [2018/12]
Representative(s)Keil & Schaafhausen Patentanwälte PartGmbB
Bockenheimer Landstraße 25
60325 Frankfurt am Main / DE
[N/P]
Former [2018/12]Keil & Schaafhausen Patent- und Rechtsanwälte PartGmbB
Friedrichstrasse 2-6
60323 Frankfurt am Main / DE
Application number, filing date16792197.212.05.2016
[2018/12]
WO2016CN81796
Priority number, dateCN20151024307513.05.2015         Original published format: CN201510243075
[2018/12]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016180347
Date:17.11.2016
Language:ZH
[2016/46]
Type: A1 Application with search report 
No.:EP3295948
Date:21.03.2018
Language:EN
[2018/12]
Search report(s)International search report - published on:CN17.11.2016
(Supplementary) European search report - dispatched on:EP22.11.2018
ClassificationIPC:A61K36/8968, A61P9/06
[2018/12]
CPC:
A61K36/8968 (EP,US); A61K36/718 (KR); A61K36/076 (KR,US);
A61K36/185 (US); A61K36/258 (KR,US); A61K36/282 (KR,US);
A61K36/484 (US); A61K36/489 (KR,US); A61K36/62 (KR);
A61K36/736 (US); A61K36/75 (KR); A61K36/752 (US);
A61K36/8888 (KR,US); A61P9/06 (KR,US); A61K2236/00 (US);
A61K2300/00 (KR) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/12]
TitleGerman:VERWENDUNG EINER ZUSAMMENSETZUNG NACH ART DER TRADITIONELLEN CHINESISCHEN MEDIZIN BEI DER HERSTELLUNG VON PHARMAZEUTISCHEN KALIUMIONENKANALMODULATOREN[2018/12]
English:USE OF TRADITIONAL CHINESE MEDICINE COMPOSITION IN PREPARATION OF POTASSIUM ION CHANNEL MODULATOR MEDICINE[2018/12]
French:UTILISATION D'UNE COMPOSITION DE MÉDECINE TRADITIONNELLE CHINOISE DANS LA PRÉPARATION D'UN MÉDICAMENT MODULATEUR DES CANAUX POTASSIQUES[2018/12]
Entry into regional phase23.11.2017Translation filed 
23.11.2017National basic fee paid 
23.11.2017Search fee paid 
23.11.2017Designation fee(s) paid 
23.11.2017Examination fee paid 
Examination procedure23.11.2017Examination requested  [2018/12]
23.11.2017Date on which the examining division has become responsible
14.06.2019Amendment by applicant (claims and/or description)
07.09.2020Despatch of a communication from the examining division (Time limit: M04)
15.01.2021Reply to a communication from the examining division
29.03.2021Despatch of a communication from the examining division (Time limit: M04)
10.08.2021Application deemed to be withdrawn, date of legal effect  [2022/01]
31.08.2021Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2022/01]
Fees paidRenewal fee
25.05.2018Renewal fee patent year 03
29.05.2019Renewal fee patent year 04
29.05.2020Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.05.202106   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]CN100490787C  (BAOAN WANG [CN]) [X] 1,4-7 * the whole document * [Y] 1-7;
 [Y]  - Jw Liu ET AL, "Protective effect of Yixinshu capsule on myocardial ischemia reperfusion injury in rats", (20130101), URL: http://www.ncbi.nlm.nih.gov/pubmed/24066601, (20181026), XP055519518 [Y] 1-7 * abstract *
International search[A]JPH0789863  (MORISHITA PHARMA, et al) [A] 1-7* , abstract *;
 [Y]CN1634206  (WANG BAOAN [CN]) [Y] 1-7 * , claims 1-2 *;
 [Y]CN104483408  (WANG BAOAN) [Y] 1-7 * , description, paragraphs 002-003 *;
 [PX]CN104825782  (SHAANXI MOMENTUM PHARMACEUTICAL CO LTD) [PX] 1-7 * , claims 1-7 *;
 [Y]  - YUAN, SIWEN;, "Observation on Sixty Cases of Rapid Arrhythmia Treated with Xinsuning Capsules", JOURNAL OF SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE, (20000731), vol. 24, no. 4, pages 290 - 293, XP 055497779 [Y] 1-7
 [Y]  - LIN, LEI et al., "26 Cases of Frequent Ventricular Procontraction Treated with Xinsuning Capsules", PEOPLE'S MILITARY SURGEON, (20110601), vol. 54, no. 6, page 512, XP009507368 [Y] 1-7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.